HT9427-26-Q-E008-0001.pdf

This is an Amendment of Solicitation/Modification of Contract (Standard Form 30) issued by the Defense Health Agency Medical R&D Contracting Division 2 on April 22, 2026. The amendment number is HT942726QE008 and applies to requisition HT9427. The issuing office contact is Jennifer Bassett at the Defense Health Agency in Fort Detrick, Maryland.

The amendment provides answers to three contractor questions regarding a Performance Work Statement (PWS) for drug testing services. Question #1 addresses the workload breakdown for hazardous drugs testing, clarifying that the PWS lists six possible drugs that clients could request (5-Fluorouracil, Methotrexate, Ifosfamide, Cyclophosphamide Monohydrate, Doxorubicin Hydrochloride, and Paclitaxel) in any combination, with historical data showing 17 clients requesting one drug each per sample. Question #2 confirms that the Government will supply the testing wipes. Question #3 clarifies that the client (government) will collect the samples, not the contractor's technicians, making this a lab-only contract. Contractors must acknowledge receipt of this amendment prior to offer submission.